At LBT Innovations, we have proven experience managing the end-to-end product development process from initial innovation, through to proof-of-concept, commercialisation and sales. Our history is founded on identifying the unmet need and bringing new technologies to market.
With MicroStreak, LBT’s first invention, and the APAS® Independence (our second), we managed the process of taking a product to market and delivering sales. Understanding the key steps in product development and navigating the end-to-end process in a regulated environment are key differentiators that set us apart. Throughout this process we have developed internal capability in systems and resources to continue to bring new technologies to market.
End-to-End Process Management
Innovation to Final Product
Our dedicated engineering team have proven capability taking new ideas through proof-of-concept, to final product development. We understand the process of transforming early stage research into a product that meets the user’s unmet need.
Medical Device Software
We understand what is required to develop medical device software (IEC 62304). Our people are experienced in software engineering and we have mature quality management systems to support medical device software development.
We have established procedures and processes for managing the in-vitro diagnostic studies required to demonstrate the performance of our APAS technology, including developing our bespoke Data Collection System (DCS) software.
A key part of bringing a medical device to market is understanding the regulatory requirements for your product and having a strategy to navigate these. At LBT, we have extensive experience commercialising new technologies across a range of geographies (e.g. FDA, CE, TGA).
We understand the importance in maintaining a strong patent position for new technologies.
Our APAS technology is underpinned by a suite of patents that covers both the image capture device and the AI algorithm for analysing microbial growth.
Commercialising new medical technologies and understanding the path to market is key to successful innovations. We have a committed global sales team dedicated to bringing our technologies to market and managing our distributors.
Dedicated Lab Facilities
LBT operates a state-of-the-art laboratory dedicated to the development of APAS® products. The laboratory consists of a fully functioning microbiology capability, as well as hosting engineering activities. The laboratory is designed to PC2 standards, and boasts a large collection of wild and reference strains used for development activities.
28 Dalgleish Street
Thebarton, South Australia, 5031